Glycation is an on-enzymatic post-translational modification (PTM) that remains poorly understood, largely because it is unknown how it occurs selectively.U sing mass spectrometry,i tw as possible to evaluate total glycation levels, identify distinct glycated products,a ssign unique glycation sites,a nd correlate these data with chemical and structural features for ap anel of proteins glycated in vitro.I tw as determined that the extent of glycation does not correlate with pK a or surface exposure at reactive sites.Rather,the data reveal that primary sequence dictates the overall likelihood that asite will become glycated, while surrounding structure further sculpts the glycation outcome.C lustered acidic residues were found to prevent glycation, whereas acombination of tyrosine and polar residues appear to promote glycation. This work contributes important new knowledge about the molecular features that govern selective glycation.
Glycation is an on-enzymatic post-translational modification (PTM) in which sugars or sugar-derived metabolites are covalently attached to protein amino or guanidino groups through the Maillard reaction. [1, 2] This process yields achemically heterogeneous set of modifications known as advanced glycation end-products (AGEs;F igure 1). [3, 4] Glycation is ahallmark of molecular aging associated with neurodegenerative,cardiovascular,and metabolic diseases,and age-related diseases of the skin and eye. [5] [6] [7] [8] [9] [10] AGE-dependent changes in function have been reported for several proteins,i ncluding collagen, [11] a-lens crystallin, [12] Hsp27, [13] and p300. [14] Although such studies demonstrate that glycation impacts protein activity and may influence disease development, we do not currently understand what controls the susceptibility of certain proteins to become glycated. This remains an open question preventing am olecular understanding of the biological role of glycation. Prior work has established that glycation occurs selectively for many proteins,i ncluding hemoglobin, [15] [16] [17] human serum albumin, [18, 19] ribonuclease, [20] and a-lens crystallin. [12] However,e ach study has focused on one or two proteins only,a nd/or was performed using different conditions that preclude direct comparison. As ar esult, these remain isolated instances that have not coalesced into ag eneral appreciation for how selective glycation arises.
Herein we report amethodical study of selective glycation for an array of proteins in vitro using mass spectrometry (MS). Though cell-based proteomic studies are well-suited for identifying AGE-modified proteins, [21] [22] [23] [24] [25] they struggle with the heterogeneity intrinsic to cellular glycation. Forinstance, the cell contains many biologically relevant aldehydes, [26] each of which can influence the preferred sites of glycation and can form numerous distinct and/or isomeric AGEs. [16] [17] [18] Thus, cataloging cellular glycation events may not reveal the underlying chemical features that govern preferential glycation. In contrast, our approach offers ap ractical, advantageous alternative by limiting the number of glycating agents at play,a voiding artifacts that arise from differential protein expression levels,and simplifying the identification of any,not only expected, AGEs.A dditionally,g lycation levels can be compared directly,asall proteins are modified using identical conditions.A saresult, it was possible to assess the total extent of glycation, identify discrete glycation adducts, catalogue locations where glycation occurs,a nd cross-reference with chemical and structural features at each site.T his enabled us to discern, and experimentally validate,key trends that control selective glycation. Therefore,t his work has significantly advanced our collective understanding for how glycation is able to occur selectively,even in the absence of an enzyme.
To begin, we assessed the reaction between ap anel of purified proteins (Supporting Information, Table S1 ) and methylglyoxal (MGO) in vitro.MGO is a1,2-dicarbonyl with enhanced electrophilicity and is among the most potent and prevalent glycating agents in vivo. [27] [28] [29] Upon treatment with MGO,n umerous adducts and variable extents of glycation were observed by LC-MS (Supporting Information, Table S1 , Figures S1-S4). We found that the amount of modification did not correlate with the total number of nucleophilic residues, the number of Lyso rA rg, or pI (Supporting Information, Figure S5 ). Thel ack of any correlations at the intact protein level suggested that individual chemical and structural features at each site control the glycation outcome.
Sites of selective glycation were identified by tryptic digestion after MGO treatment. Glycation at Arg or Lys prevents trypsin cleavage at that site,a llowing us to identify modified peptides as missed cleavages (Supporting Information, Figure S6 ). Owing to potential changes in ionization following glycation, and the large number of distinct and/or isomeric products,w ec alculated approximate conversion by comparing the amount of unmodified peptide in MGO treated and untreated samples (Supporting Information, Equation S1;T able S2). [30] This data was used to generate frequency logos depicting the five residues flanking each side of the reactive site ( Figure 2A ). To confirm that MGO concentration does not influence the site-selectivity of the reaction, the same analysis was performed using ar ange of MGO concentrations (50 mm-1 mm)f or as elect group of proteins.W ef ound that glycation occurred at the same sites for all concentrations tested, though the amount of glycation increased with the MGO concentration (Supporting Information, Figure S7 ). Next, we used structural information (available for all but four proteins) to identify residues within 5 of each glycated site ( Figure 2B ). Although this analysis did not reveal ac onsensus sequence (Figure 2A ), the frequency of residues surrounding our glycated sites differed from those neighboring all Arg in our input set and from those adjacent to as et of glycated Arg manually curated from the literature (Supporting Information, Figure S8 ). This suggested that our data set holds important clues about selective glycation.
Compared to prior studies,our data set is unique in that it enabled further analysis based on each AGEa dduct observed, the known structural features,a nd the extent of glycation at each site.Afull account of this analysis,grouped by AGEidentity or structure,can be found in the Supporting Information, Figures S9-S11 along with additional discussion. Theg reatest differences were observed when the identified sequences were sorted by the extent of glycation (> 66 %and < 33 %m odified, Figure 2C -F). Them ost apparent difference was the increased occurrence of Ty rinthe set of "mostmodified" sequences;T yr has been suggested previously to promote glycation. [18] This can be contrasted with the striking presence of Phe in the "least-modified" group.A dditionally, there was an otable decrease in the frequency of acidic residues found surrounding glycated sites in the "mostmodified" sequences.S everal studies have highlighted the enrichment of acidic residues surrounding glycated sites, [15, 21, 31, 32] which is also reflected in our complete data set and the "literature" set of glycated sequences (Figure 2A,B ;Supporting Information, Figure S8 ). However,the importance of negative charge has been controversial, as some reports suggest that acidic residues are detrimental, [15] but others propose that they promote glycation. [21, 31, 32] In our case,t he decrease in the frequency of acidic residues in the "most-modified" sequences was concomitant with an increase in the occurrence of Asn, Cys,P ro,S er,a nd Thr. Although none of these differences met the criteria for statistical significance,t he observed trends led us to build several hypotheses about features that could influence glycation. In particular,this analysis suggests that the presence of tyrosine and polar groups,and perhaps proline,could enable glycation at ap articular site.
Next, we incorporated structural considerations into our analysis.W ed etermined the residue accessible surface area (ASA) using the VA DARa lgorithm, which calculates the residue surface area that awater molecule can "touch". [33] The pK a for each glycated Arg was also estimated using PROPKA, aw idely used empirical program for predicting pK a . [34] We found no correlation between the extent of glycation at each site and ASA ( Figure 2G )o rp K a (Figure 2H ). Although this conflicts with prior hypotheses that Arg pK a perturbations govern glycation, [18, 32, [35] [36] [37] it was not surprising to us based on the diversity of our glycated sequences.M oreover,i fg lycation were purely driven by nucleophile pK a ,preferential glycation would be observed at the N-terminus or Lys, rather than Arg. From am echanistic standpoint, this likely reflects that imine formation, the first step in the Maillard reaction, occurs readily and reversibly on amino and guanidino groups throughout the protein. [1, 2, [38] [39] [40] [41] Instead, selective glycation is more likely driven by polar or ionizable groups that promote later, rate-determining rearrangements,w hich may vary depending on the mechanism through which each adduct forms. [42, 43] To disentangle the effect of sequence from that of structure on the glycation outcome,w ee xamined the glycation of proteins that were unfolded prior to MGO treatment. We focused on ubiquitin, ribonuclease A, and myoglobin, as these proteins exhibited high, medium, and low levels of glycation, respectively (Supporting Information, Figure S1 ). We confirmed that commonly used chaotropic denaturants,s uch as guanidinium chloride and urea, completely prevented glycation (Supporting Information , Figure S12) . As an alternative,w ee stablished that 50 % tertbutanol does not significantly alter total levels or distributions of AGEa dducts,a nd can be used to denature proteins (Supporting Information, Figure S12 , Figure S13 A,B ). For proteins that were unfolded using this method prior to MGO treatment, we observed modestly increased levels of glycation by intact MS (Supporting Information, Figure S13 C-E). While this was most apparent for myoglobin, western blot analysis of glycated ribonuclease and ubiquitin confirmed that more glycation occurred for unfolded proteins (Supporting Information, Figure S13 F). Following proteolytic digest of the denatured proteins,a ll of the same sites were modified, but each contained fewer distinct AGEp roducts (Figure 3) . In other words,t hough the overall number of glycated sites was lower for folded proteins,the total number of adducts was higher. This demonstrates that when structure is lost, there is less diversity in the type of AGEs that form. Moreover,wedid not observe glycation at every possible Arg or Lys, suggesting that selective glycation occurs even for unstructured targets. Taken together,t hese results reveal that primary sequence dictates overall reactivity,w hile nearby structure sculpts the distinct outcome at each site.
Building on these findings,w ec hose to evaluate further the effect of primary sequence on glycation using short, unstructured peptides.W esynthesized three peptides: 1 (Ac-AEELEREFLAV), 2 (Ac-LADFERTGLLS), and 3 (Ac-FTPSARSQTSY), which were designed to mirror trends on either extreme of our data set ( Figure 2C-F 1 (Figure 4) . These data confirm that differences in primary sequence result in differences in both overall glycation and the distribution of AGEs.T his result is significant because past work has considered sequence and structure together, making it extremely difficult to examine them as independent variables that, on their own, provide specific contributions to the glycation outcome.M oreover,t hese results reveal that multiple acidic residues within the same sequence are detrimental to reactivity,e ven though they were abundant in our modified sequences.T hey also suggest that Ty ra nd polar residues can promote glycation.
Our next goal was to use these findings to inform an experiment that could test of our understanding of the rules governing selective glycation. To do so,weselected peptides 4 (Ac-GLDNYRGYSLG) and 5 (Ac-NALLVRYTKKV) to prepare from our set of highly modified sequences (Figure 2C-F;S upporting Information, Table S2 ). As both contained at least one Tyra nd several polar residues,t hey were expected to be substantially modified. From the least modified set, we selected peptide 6 (Ac-FAELERIGSEV), which we anticipated to be minimally glycated owing to its three acidic residues.W ea lso chose peptide 7 (Ac-ISPYYRQSLFR), which did not match the trends expected for sequences with low reactivity.I nstead, we hypothesized that the multiple Ty ra nd polar groups would promote glycation. Indeed, after 24 ho ft reatment with MGO, 5 was the most glycated, while 4 also exhibited moderate reactivity ( Figure 4 ). As expected, 6 was the least modified and 7 displayed moderate reactivity similar to that of peptide 4 after 24 ho fM GO treatment. Strikingly,a ts horter incubation times (3 h), peptide 7 yielded the highest levels of glycation for any peptide tested. These studies provide important validation about features that control selective glycation: 1-3 permitted us to test experimentally the trends we uncovered; these results enabled us to correctly predict relative levels of glycation for select isolated peptides (4-7).
To further evaluate the specific sequence contributions that govern selective glycation, as eries of point mutants to peptide 4 were prepared ( Figure 5 ; Supporting Information, Figure S15 ). We chose to explore these effects for peptide 4 because it contains two Ty ra nd multiple polar residues that were determined to be beneficial for glycation (Figures 2and  4) . However,l ike many of the glycation sites we identified (Supporting Information, Table S2 ), it also possesses asingle Asp,p roviding an opportunity to reconcile the role of an isolated negative charge in influencing the glycation outcome. First, we evaluated the effect of removing the two Ty ra nd replacing them with Phe,Ser, or Asp (peptides 4a, 4b,and 4c, respectively;F igure 5A). Forall of these variants,the extent of glycation was decreased relative to that observed for peptide 4.Alarger decrease in the amount of glycation was observed for peptide 4a (Tyr to Phe) than for 4b (Tyr to Ser), suggesting that the hydroxyl group of Ty rhas agreater effect than its aromatic core in influencing glycation. Moreover,the reduction in glycation was most dramatic for peptide 4c, which introduced two additional acidic residues.T ogether, these observations provide further confirmation that multiple negative charges within as equence are detrimental for glycation, and support the importance of Ty ra nd polar residues as beneficial for glycation.
Our subsequent studies aimed to assess the role of substitution in several positions throughout the peptide 4 scaffold (peptides 4d-n, Figure 5B -D). Although we established that removal of Tyrw as detrimental to glycation, we found that introduction of an additional Ty rl ed to either no change or slightly lower levels of glycation (4d and 4i). The same was true for the introduction of polar residues such as Gln (4f)o rS er (4g and 4m). Indeed, none of the point Figure 4 . A) Depiction of the glycation of synthetic peptides with MGO. B) Distribution of glycation products observed for 1-7 after treatment with MGO (n ! 3). Careful MS/MS analysis was performed in addition to our standard quantification protocol (see the Supporting Information). This enabled the quantification of glycation that had taken place at only the central Arg for peptides 5 and 7,w hich both contain multiple potentialglycation sites. However,all trends remained the same when considering "total glycation", which considers modification at all sites (Supporting Information, Figure S14 ). Tukey HSD performed separately for 1-3 and 4-7;p< 0.005(**), p < 0.0005 (***), p < 0.0001 (****). mutants we prepared led to increased levels of glycation compared to peptide 4.H owever,w ef ound that the introduction of Pro led to as ignificant decrease in the amount of glycation observed (4h and 4k). Additionally,the introduction of Glu (4e and 4j)c onsistently led to significantly less glycation relative to peptide 4.However,when the single negative charge in peptide 4 was substituted with Gly, Ser,o rP ro (4l-n), levels of glycation remained fairly constant. This suggests that, while clustered acidic residues consistently decrease levels of glycation, as ole negative charge may be important for glycation. Taken together,these experiments provide further validation that Ty ra nd polar residues are helpful for glycation, whereas the introduction of multiple acidic residues is disadvantageous.Asaresult, this is the first report, to our knowledge,toexperimentally validate guidelines for selective glycation that have the potential to be generalized across different substrates.
Past studies of selective glycation with MGO have rationalized findings individually without further experimental validation (see the Supporting Information, Figure S8 for ac omplete reference list). This has led to many ideas about features that might promote glycation but few,ifany,that can be generalized. Therefore,our goal was to perform asystematic study that would contribute robust information about how selective glycation arises.W ec onclude that primary sequence primarily governs the propensity of as ite to be glycated, whereas the surrounding structure refines the specific glycation outcome.O ur experiments validated that clustered negative charge is detrimental to glycation, and suggests that acombination of tyrosine and polar residues are beneficial. Our future work will focus on fully reconciling the effect of individual negative charges,which frequently appear in glycated sequences that we,a nd others, [15, 21, 31, 32] have identified. We will also evaluate further how the positional preferences for surrounding residues affect the distribution and/or identities of AGEs that form. Further studies to define the influence of structure are also underway.Such knowledge will enable the development of new tools that can be used to advance our understanding of glycation as afunctional PTM. Figure 5 . Distribution of glycation products observed for aseries of single-and double-pointm utations to peptide 4 (peptides 4a-n)after 24 htreatment with MGO (n ! 3). Fort he reaction scheme, please refer to Figure 4A .T oaid in interpretation, these data are groupedb y the position, relative to Arg, where substitutions were made:A)Position À1/ + 2(4a-c); B) Position + 1( 4d-h); C) Position À2( 4i-k); and D) Position À3(4l-n). Tukey HSD comparingtopeptide 4; p < 0.05(*), p < 0.005(**), p < 0.0005 (***).
